产品封面图
文献支持

Anti-Mouse Mu-type opioid rece

ptor/OPRM1/μOR Nanobody (SAA2285)
收藏
  • ¥1668
  • abinScience
  • China
  • MA561013
  • 2025年07月25日
  • ELISA, IF, FCM
  • Human
  • Mouse
avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 免疫原

      Human

    • 亚型

      VHH-hFc

    • 形态

      Liquid

    • 保存条件

      0.01M PBS, pH 7.4.

    • 克隆性

      Monoclonal

    • 标记物

      Unconjugated

    • 适应物种

      Mouse

    • 保质期

      1 year

    • 抗原来源

      Human

    • 目录编号

      MA561013

    • 级别

      科研级别

    • 库存

      999

    • 供应商

      abinScience

    • 宿主

      Human

    • 应用范围

      ELISA, IF, FCM

    • 浓度

      1mg/mL

    • 靶点

      Mu-type opioid receptor, M-OR-1, MOR-1, Mu opiate receptor, Mu opioid receptor, MOP, hMOP, OPRM1

    • 抗体英文名

      Anti-Mouse Mu-type opioid receptor/OPRM1/μOR Nanobody (SAA2285)

    • 抗体名

      Anti-Mouse Mu-type opioid receptor/OPRM1/μOR Nanobody (SAA2285)

    • 规格

      100ul

    产品细节图片1

    Product nameAnti-Mouse Mu-type opioid receptor/OPRM1/渭OR Nanobody (SAA2285)
    Catalog No.MA561013
    Host speciesHuman
    Species reactivityMouse
    Immunogen/
    FormLiquid
    Storage buffer0.01M PBS, pH 7.4.
    Purity>90% as determined by SDS-PAGE.
    ClonalityMonoclonal
    IsotypeVHH-hFc
    ApplicationsELISA, IF, FCM
    TargetMu-type opioid receptor, M-OR-1, MOR-1, Mu opiate receptor, Mu opioid receptor, MOP, hMOP, OPRM1
    PurificationProtein A/G purified from cell culture supernatant.
    Endotoxin levelPlease contact with the lab for this information.
    Expression system/
    AccessionP42866
    Alternative Names/
    Clone IDSAA2285
    Species/
    Product Usage Information/

    abinScience, founded in 2023 in Strasbourg, France, is committed to developing and producing high-quality life science reagents. Rooted in one of Europe’s leading hubs for scientific innovation, abinScience empowers global research through reliable, efficient experimental solutions. Guided by the vision of “Empowering Bioscience Discovery,” we support scientists worldwide in advancing the frontiers of bioscience.

     

    Technology and Innovation

    Relying on the global leading position in antibody and protein research and more than 20 years of industry experience of its parent company ProteoGenix since 2003, abinScience has inherited advanced technologies and high-quality standards. In particular, the XtenCHO™ system developed by ProteoGenix, which has two modes of transient expression and stable expression, has been widely recognized as a core technology to improve the efficiency of protein production, providing a solid foundation for abinScience's product research and development.

     

    Product categories and application fields.

    Main products.
    10000+ high-activity proteins.
    15000+ antibody series products:
    Classic monoclonal antibody.
    Monoclonal antibody
    Internal control antibody, labeled antibody.
    High-quality phosphorylation antibodies.
    Highly specific nanobodies and small molecule antibodies.
    Functional antibodies in vivo.
    Low-background flow cytometry antibodies.
    DNA/RNA antibodies and PEG antibodies.
    1000+ reagent kit series products.
    Large-scale packaging customization services: We offer personalized antibody design, protein production, molecular optimization, and experimental development services.


    Application field

    Infectious disease research: including viruses, superbugs, parasites, etc.
    Neuroscience research: Supporting research on neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
    Immunology research: Covers the research needs of immune activation, inhibition, and allergies and abnormal reactions.
    Oncology research: Supporting the development of tumor biology and anti-tumor drugs.

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献
    • Impact of OPRM1 (Mu-opioid Receptor Gene) A112G Polymorphism on Dual Oxycodone and Cocaine Self-administration Behavior in a Mouse Model., PMID:38211933
    • How individual sensitivity to opiates can be predicted by gene analyses., PMID:15925706
    • Pharmacogenomics of the human µ-opioid receptor., PMID:21919606
    • Mu-opioid receptor A118G polymorphism in healthy volunteers affects hypothalamic-pituitary-adrenal axis adrenocorticotropic hormone stress response to metyrapone., PMID:21507151
    • Impact of Pain, Opioids, and the Mu-opioid Receptor on Progression and Survival in Patients With Newly Diagnosed Stage IV Pancreatic Cancer., PMID:32482952
    • M3 muscarinic acetylcholine receptor facilitates the endocytosis of mu opioid receptor mediated by morphine independently of the formation of heteromeric complexes., PMID:28411124
    • Differential use of an in-frame translation initiation codon regulates human mu opioid receptor (OPRM1)., PMID:19609488
    • Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists., PMID:31807708
    • Is there genetic polymorphism evidence for individual human sensitivity to opiates?, PMID:17367590
    • Genome-wide loss-of-function genetic screening identifies opioid receptor μ1 as a key regulator of L-asparaginase resistance in pediatric acute lymphoblastic leukemia., PMID:28650467
    相关实验
    • In Vitro Opioid Receptor Assays

      . Pharmacol. 55:4.8.1?4.8.34. © 2011 by John Wiley & Sons, Inc. Keywords: opioid receptors; mu opioid receptors; kappa opioid receptors; delta opioid receptors; in vitro assays; mouse; guinea pig; longitudinal muscle/myenteric plexus; vas

    • viral immunity

      ., Schroder, W., Zirngibl, H. and Nieswandt, B. (2000). Structural and functional characterization of the mouse von Willebrand factor receptor GPIb-IX with novel monoclonal antibodies . Blood 95(3): 886-93. Bizzaro, N. and Fiorin, F. (1999

    • viral immunity pathogenesis group

      ., Schroder, W., Zirngibl, H. and Nieswandt, B. (2000). Structural and functional characterization of the mouse von Willebrand factor receptor GPIb-IX with novel monoclonal antibodies . Blood 95(3): 886-93. Bizzaro, N. and Fiorin, F. (1999

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥993
    广州市左克生物科技发展有限公司
    2025年09月02日询价
    询价
    普健生物(武汉)科技有限公司
    2025年09月01日询价
    询价
    广州东锐科技有限公司
    2025年12月16日询价
    询价
    维百奥(北京)生物科技有限公司
    2025年09月15日询价
    文献支持
    Anti-Mouse Mu-type opioid receptor/OPRM1/μOR Nanobody (SAA2285)
    ¥1668